STAT1 (Ab-701) Antibody

What is STAT1 and why is Y701 phosphorylation important?

STAT1 (Signal Transducer and Activator of Transcription 1) is a transcription factor that mediates cellular responses to interferons and other cytokines. Phosphorylation at tyrosine 701 (Y701) is a critical post-translational modification that occurs following interferon stimulation. This phosphorylation event enables STAT1 dimerization, nuclear translocation, DNA binding, and subsequent activation of interferon-stimulated genes. The phosphorylation status of STAT1 at Y701 serves as a key marker for monitoring interferon signaling pathway activation in various experimental contexts . Understanding this modification is essential for investigations into immune responses, particularly in studies of antiviral immunity, autoimmune disorders, and cancer research.

What applications are suitable for phospho-STAT1 (Y701) antibodies?

Phospho-STAT1 (Y701) antibodies can be utilized in multiple experimental applications:

• Western Blot/Immunoblotting: Detects phosphorylated STAT1 at approximately 84-94 kDa, allowing for quantitative assessment of activation status .

• Flow Cytometry: Enables single-cell analysis of STAT1 phosphorylation status, particularly useful for heterogeneous cell populations .

• Simple Western™: An automated capillary-based immunoassay that provides quantitative data with high reproducibility .

• Immunohistochemistry (IHC): For detection of phosphorylated STAT1 in tissue sections, as evidenced by application in breast cancer tissue samples .

• Microarrays/ELISA: Can be used for high-throughput detection of phosphorylated STAT1 in serum and plasma samples .

• Co-immunoprecipitation: For studying protein-protein interactions involving phosphorylated STAT1 .

Each application requires specific optimization of antibody concentration, incubation conditions, and detection methods to maximize specificity and sensitivity.

How do I validate the specificity of a phospho-STAT1 (Y701) antibody?

Validating antibody specificity is crucial for reliable experimental outcomes. A comprehensive validation approach includes:

• Positive and negative controls: Use IFN-α/β-stimulated cells (positive control) and unstimulated cells (negative control). For example, Daudi cells (human Burkitt's lymphoma) treated with recombinant human IFN-α for 20 minutes show significant induction of Y701 phosphorylation .

• Phosphatase treatment: Treating lysates with phosphatases should abolish antibody recognition if it's truly phospho-specific.

• Phospho-mimetic mutants: Using STAT1-Y701F mutants as negative controls can confirm specificity, as these cannot be phosphorylated at position 701 .

• Knockdown/knockout validation: STAT1-deficient cells (STAT1^-/-) should show no signal with the antibody .

• Cross-reactivity testing: Test across species if working with animal models, as some antibodies recognize both human and mouse phospho-STAT1 (Y701) .

Documentation of these validation steps is essential for publication-quality research and reproducible results.

How does STAT1 acetylation interact with Y701 phosphorylation?

The relationship between STAT1 acetylation and Y701 phosphorylation remains controversial in the scientific literature. Two competing models exist:

Model 1: Krämer et al. proposed that acetylation of STAT1 at Lys410 and Lys413 inhibits IFN-regulated gene expression by promoting the recruitment of phosphatase TC45, which dephosphorylates Y701. According to this model, HDAC inhibitors (HDACi) like TSA (30 nM) or VPA (1.5 mM) suppress STAT1 tyrosine phosphorylation by promoting acetylation .

Model 2: Contrary evidence suggests no direct relationship between acetylation and phosphorylation. Some researchers failed to detect STAT1 acetylation following IFN-α treatment even in the presence of HDACi, and did not observe impaired STAT1 phosphorylation associated with acetylation .

To investigate this interaction, researchers should:

• Employ acetylation-mimicking mutants (KK410/413QQ)

• Use phosphatase inhibitors (vanadate) to determine if phosphorylation can be rescued

• Apply multiple detection methods beyond immunodetection (e.g., mass spectrometry) to verify acetylation status

• Carefully control for experimental conditions, as SV40 large T antigen expression in 293T cells might influence results through interactions with p300/CBP

These contradictory findings highlight the complexity of STAT1 post-translational modifications and the need for rigorous experimental controls when investigating their interplay.

What non-canonical functions of STAT1 can be studied using phospho-specific antibodies?

Beyond its canonical role in transcriptional regulation, STAT1 exhibits non-canonical functions that can be investigated using phospho-specific antibodies:

• Natural Killer cell cytotoxicity: STAT1 plays a phosphorylation-independent role in NK cell cytotoxic function. Mass spectrometry analysis identified 153 STAT1-binding proteins in murine NK cells, with 63% showing increased association upon target cell co-incubation .

• Protein-protein interactions outside the nucleus: Gene ontology analysis revealed unexpected STAT1 associations with cell junctions, membranes, and membrane-bound vesicles, suggesting extranuclear functions .

• Comparative studies using STAT1-Y701F mutants: These phosphorylation-deficient mutants allow researchers to distinguish between canonical (phosphorylation-dependent) and non-canonical (phosphorylation-independent) STAT1 functions .

When designing experiments to study these non-canonical functions, researchers should:

• Use multiple detection methods (co-IP followed by Western blot and mass spectrometry)

• Optimize lysis buffers (e.g., 50 mM HEPES pH 7.5, 0.1% Tween-20, 150 mM NaCl, etc.) to preserve protein-protein interactions

• Include appropriate controls (input, not-bound fraction, and IP fraction)

• Consider complementary approaches like proteomics and functional assays

How do different stimuli affect the kinetics and magnitude of STAT1 Y701 phosphorylation?

The phosphorylation dynamics of STAT1 at Y701 vary substantially depending on the stimulus:

Interferon-α/β (Type I IFNs):

• Rapid phosphorylation typically detectable within 5-15 minutes

• Maximum phosphorylation around 20-30 minutes post-stimulation

• In Daudi cells, 20 minutes of treatment with recombinant human IFN-α shows robust phosphorylation

Interferon-γ (Type II IFN):

• Similar rapid phosphorylation kinetics

• May show more sustained phosphorylation compared to Type I IFNs

Other cytokines and growth factors:

• IL-6, IL-10, and growth factors can also induce STAT1 Y701 phosphorylation but with different kinetics and magnitude

• Often results in weaker and more transient phosphorylation compared to interferons

To accurately capture these dynamics, researchers should:

• Perform time-course experiments with multiple timepoints (0, 5, 15, 30, 60, 120 minutes)

• Use appropriate positive controls (e.g., 500 units/mL recombinant human IFN-α for 20 minutes in Daudi cells)

• Consider dose-response relationships to determine optimal stimulus concentration

• Account for cell type-specific differences in phosphorylation responses

What are the optimal protocols for detecting phospho-STAT1 (Y701) by Western blot?

A successful Western blot protocol for phospho-STAT1 (Y701) detection requires careful attention to several critical parameters:

Sample Preparation:

• Stimulate cells with appropriate cytokines (e.g., 100 U/mL rmIFN-β for 10 minutes)

• Lyse cells in buffer containing phosphatase inhibitors (e.g., 10 mM β-glycerophosphate, 1 mM NaF, 500 nM Na₃VO₄)

• Maintain samples at 4°C throughout processing to preserve phosphorylation

• Process samples quickly to minimize dephosphorylation

Western Blot Protocol:

• Separate proteins on 7-10% SDS-PAGE gels for optimal resolution of STAT1 (~90 kDa)

• Transfer to PVDF or nitrocellulose membranes

• Block with 5% BSA (not milk, which contains phosphatases)

• Incubate with anti-phospho-STAT1 (Y701) antibody at optimized dilution (e.g., 0.5 μg/mL)

• Use appropriate HRP-conjugated secondary antibodies

• Visualize using chemiluminescent detection systems

Antibody Concentrations and Conditions:

• Primary antibody: 1:2000 dilution, 4°C overnight incubation has been reported effective

• Secondary antibody: 1:5000 dilution, room temperature, 1 hour

• For multiplex detection, consider using IR-dye labeled secondary antibodies

Common Troubleshooting Tips:

• High background: Increase blocking time, use fresh blocking agent, optimize antibody dilutions

• Weak signal: Ensure adequate protein loading, check phosphatase inhibitors are active, reduce washing stringency

• Multiple bands: Verify antibody specificity, optimize SDS-PAGE conditions, consider using phosphatase treatment controls

How can I optimize flow cytometry protocols for intracellular phospho-STAT1 (Y701) detection?

Flow cytometry provides single-cell resolution of phospho-STAT1 levels but requires specific optimization:

Cell Preparation Protocol:

• Stimulate cells appropriately (e.g., 500 units/mL recombinant human IFN-α for 20 minutes)

• Fix cells with paraformaldehyde (typically 2-4%) to preserve phosphorylation status

• Permeabilize with methanol (100% ice-cold methanol is often effective)

• Block with appropriate buffer to reduce non-specific binding

Staining Protocol:

• Incubate with primary anti-phospho-STAT1 (Y701) antibody at optimized concentration

• Wash thoroughly to remove unbound antibody

• Incubate with fluorochrome-conjugated secondary antibody (e.g., Allophycocyanin-conjugated Anti-Rabbit IgG)

• Include appropriate isotype control antibodies

Critical Considerations:

• Fixation and permeabilization conditions drastically affect epitope accessibility

• Include unstimulated cells as negative controls and strongly stimulated cells as positive controls

• For multiparameter analysis, include fluorescence minus one (FMO) controls

• Consider using directly conjugated phospho-specific antibodies to reduce protocol time and variability

Data Analysis Tips:

• Display data as histogram overlays of unstimulated versus stimulated samples

• Calculate fold change in median fluorescence intensity (MFI)

• For heterogeneous populations, use appropriate gating strategies to identify responsive subpopulations

• Consider using phospho-flow analysis software for complex datasets

What are the key considerations for co-immunoprecipitation studies involving phospho-STAT1?

Co-immunoprecipitation (Co-IP) is valuable for studying STAT1 protein interactions but requires careful optimization:

Optimized Co-IP Buffer Composition:

• 50 mM HEPES pH 7.5

• 0.1% Tween-20

• 150 mM NaCl

• 1 mM EDTA

• 10 mM β-glycerophosphate

• 1 μM PMSF

• 1 mM NaF

• 500 nM Na₃VO₄

• Complete Protease Inhibitor Cocktail

Sample Preparation:

• Use sufficient cell numbers (e.g., 3 × 10⁶ NK cells per condition)

• Stimulate appropriately (e.g., 100 U/mL rmIFN-β for 10 minutes)

• Lyse cells in optimized buffer at 4°C

• Clear lysates by centrifugation (typically 15 min at 4°C)

Co-IP Procedure:

• Pre-clear lysates with protein A/G beads if necessary

• Incubate with antibody-conjugated beads (e.g., ANTI-FLAG M2 Affinity Gel for tagged proteins)

• Wash extensively to remove non-specific binding

• Elute bound proteins (e.g., by boiling in Laemmli buffer with β-mercaptoethanol)

Essential Controls:

• Input control (5% of whole cell lysate)

• Bead-supernatant control (5% of not-bound fraction)

• IgG control to assess non-specific binding

• Phosphatase-treated samples if studying phosphorylation-dependent interactions

Detection Methods:

• Western blotting with specific antibodies against proteins of interest

• Mass spectrometry for unbiased identification of interaction partners

• For complex interactions, consider using proximity ligation assays as complementary approaches

How should I interpret conflicting data on STAT1 phosphorylation patterns?

Researchers frequently encounter contradictory results when studying STAT1 phosphorylation. A systematic approach to resolving these conflicts includes:

Potential Sources of Discrepancies:

• Cell type differences: STAT1 phosphorylation patterns vary significantly between cell types due to differences in receptor expression, JAK levels, and phosphatase activity

• Experimental conditions: Minor variations in cell density, serum starvation protocols, or stimulation concentrations can dramatically affect outcomes

• Antibody specificity issues: Different antibody clones may recognize distinct phosphorylated species or show cross-reactivity

• Technical variations: Differences in lysis buffers, handling time, and protein extraction methods impact phosphorylation detection

Resolution Strategies:

• Standardize experimental conditions: Use consistent cell densities, passage numbers, and stimulation protocols

• Employ multiple detection methods: Complement Western blot with flow cytometry or ELISA

• Include appropriate controls: Always run positive controls (e.g., IFN-α-stimulated Daudi cells) and negative controls

• Validate key findings with genetic approaches: Use STAT1-deficient cells or STAT1-Y701F mutants

• Consider kinetics and dose-response: Perform detailed time-course and dose-response experiments

When reporting conflicting results, explicitly state all experimental conditions and acknowledge limitations of the experimental approach.

What experimental design best captures the relationship between STAT1 phosphorylation and downstream functions?

To effectively link STAT1 phosphorylation status with functional outcomes, consider this experimental framework:

Comprehensive Experimental Design:

• Temporal analysis:

  • Monitor phosphorylation kinetics (0-120 minutes post-stimulation)

  • Assess downstream gene expression changes at multiple timepoints

  • Compare protein-protein interaction dynamics with functional outputs

• Genetic approaches:

  • Compare wild-type, STAT1-deficient, and STAT1-Y701F mutant responses

  • Use inducible expression systems (e.g., doxycycline-inducible STAT1)

  • Consider phosphomimetic mutations to simulate constitutive phosphorylation

• Pharmacological inhibitors:

  • JAK inhibitors to prevent phosphorylation

  • Phosphatase inhibitors to prolong phosphorylation

  • HDACi to investigate acetylation-phosphorylation crosstalk

• Functional readouts:

  • Transcriptional activity (reporter assays, RT-qPCR, RNA-seq)

  • Protein-protein interactions (co-IP, proximity ligation)

  • Cellular outcomes (proliferation, apoptosis, cytokine production)

Integrated Analysis Approaches:

• Correlate phosphorylation intensity with functional outcome measures

• Use multivariate analysis to identify key determinants of functional responses

• Consider mathematical modeling to capture complex phosphorylation-dependent signaling networks

How can I differentiate between canonical and non-canonical functions of STAT1 in my experimental system?

Distinguishing canonical (phosphorylation-dependent, transcriptional) from non-canonical STAT1 functions requires strategic experimental design:

Key Experimental Approaches:

• Genetic tools:

  • STAT1-Y701F mutants: Unable to undergo tyrosine phosphorylation but retain other functions

  • STAT1 DNA-binding mutants: Phosphorylation-competent but transcriptionally inactive

  • Domain-specific deletion mutants: Target specific protein interaction domains

• Subcellular localization studies:

  • Immunofluorescence to track STAT1 localization

  • Subcellular fractionation followed by Western blotting

  • Live cell imaging with fluorescently tagged STAT1

• Protein interaction mapping:

  • Mass spectrometry to identify interaction partners (153 STAT1-binding proteins were identified in NK cells)

  • Categorize partners by response to stimulation (constitutive vs. stimulus-induced)

  • Gene ontology analysis to identify unexpected interaction contexts (e.g., membrane association)

• Functional assays:

  • Compare transcription-dependent vs. transcription-independent outcomes

  • Natural Killer cell cytotoxicity assays to assess non-canonical functions

  • Measure rapid responses occurring before transcriptional activation

Analytical Framework:

• Classify observed effects based on their dependency on Y701 phosphorylation

• Determine time course (immediate vs. delayed responses)

• Assess requirement for nuclear translocation and DNA binding

• Evaluate protein synthesis dependency (cycloheximide sensitivity)